Skip to content

Clinical Trial of the Abdominal Lift-Compression Cardiopulmonary Resuscitation Device

Clinical Trial of the Abdominal Lift-Compression Cardiopulmonary Resuscitation Device

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124998
Enrollment
Unknown
Registered
2026-05-20
Start date
2014-04-06
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac arrest (non-traumatic out-of-hospital cardiac arrest, with absolute contraindications for external chest compression)

Interventions

Experimental group:Using the CPR-LW1000 abdominal compression and chest compression resuscitation device, fix the suction cup at the midline of the abdomen between the xiphoid process and the umbilicu
the compression force should be 20-30 kg, the pressure force 40-50 kg, the compression-to-ventilation ratio 1:1, and the compression-to-ventilation ratio 30:2. At the same time, follow the 2010 AHA Ad

Sponsors

People's Hospital of Zhengzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged >= 18 years, body weight 40–150 kg, regardless of gender. 2.Nontraumatic out-of-hospital cardiac arrest (OHCA) requiring immediate cardiopulmonary resuscitation (CPR). 3.With absolute contraindications to chest compressions, including severe chest trauma, flail chest, multiple rib fractures, thoracic deformity, severe osteoporosis, hemopneumothorax, etc. 4.Written informed consent signed by the patient’s immediate family members or legal representatives (except for cases with ethical waiver).

Exclusion criteria

Exclusion criteria: 1.Presence of contraindications to abdominal lift-compression, including abdominal trauma, diaphragmatic rupture, abdominal aortic aneurysm, massive intra-abdominal hemorrhage, pregnancy, massive ascites, huge abdominal mass, etc. 2.Complicated with chronic consumptive diseases such as end-stage malignant tumor and severe tuberculosis that may affect the efficacy evaluation. 3.Refusal to use the abdominal lift-compression cardiopulmonary resuscitation device by the patient’s immediate family members or legal representatives.

Design outcomes

Primary

MeasureTime frame
Return of spontaneous circulation;

Secondary

MeasureTime frame
Heart rate ;Mean arterial pressure;Peripheral oxygen saturation;Rate of survival to hospital admission;Device operability and portability;Device safety (incidence of adverse events such as rib fracture, abdominal organ injury, etc.);Arterial blood pH;

Countries

China

Contacts

Public ContactQing Liu

People's Hospital of Zhengzhou

3506759327@qq.com+86 371 6707 7120

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026